Journal title
Cells

   
Home  /  Cells  /  Vol: 6 Núm: 2 Par: June (2017)  /  Article
ARTICLE
TITLE

Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The “Rotation Model”

SUMMARY

-

PAGES
COLLECTIONS
Biology

 Articles related

Made Putra Semadhi,Stefanus Layli Prasojo,Anandani Widarini    

Lung cancer is the most contributor of cancer cause death in the world. Lung cancer is related to cigarette consumption and genetic factor. Nicotine derived nitrosamine ketone is the most important inducer of lung cancer associated with DNA Mutations res... see more


A. M. ALZOHAIRY,MARGARET H. MACDONALD,RANIA B. M. AMER,BENJAMIN F. MATTHEWS    

Successful engineering of transgenic plants for resistance to nematodes requires promoters that over-express resistant genes in the proper cells at the proper time. Gene promoter region controls the temporal and spatial expression of genes. In previous r... see more


Aadhya Tiwari, Simone Rebholz, Eva Maier, Mozhgan Dehghan Harati, Daniel Zips, Christine Sers, H. Peter Rodemann and Mahmoud Toulany    

Ionizing radiation (IR) and epidermal growth factor (EGF) stimulate Y-box binding protein-1 (YB-1) phosphorylation at Ser-102 in KRAS wild-type (KRASwt) cells, whereas in KRAS mutated (KRASmut) cells, YB-1 is constitutively phosphorylated, independent of... see more


Levi Arnold, Jonathan Enders and Sufi Mary Thomas    

Head and neck squamous cell carcinoma (HNSCC) is a highly morbid disease. Recent developments including Food and Drug Administration (FDA) approved molecular targeted agent’s pembrolizumab and cetuximab show promise but did not improve the five-year surv... see more

Revista: Cancers

Zachary Schrank, Gagan Chhabra, Leo Lin, Tsatsral Iderzorig, Chike Osude, Nabiha Khan, Adijan Kuckovic, Sanjana Singh, Rachel J. Miller and Neelu Puri    

Lung cancer is treated with many conventional therapies, such as surgery, radiation, and chemotherapy. However, these therapies have multiple undesirable side effects. To bypass the side effects elicited by these conventional treatments, molecularly-targ... see more

Revista: Cancers